Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice. - Wikidata - wikimedia - TriplyDB

Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.

Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.

http://www.wikidata.org/entity/Q37665470

about

Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/- mice--role of intestinal permeability and macrophage activation Hepatic carboxylesterase 1 is induced by glucose and regulates postprandial glucose levels.Hepatic overexpression of methionine sulfoxide reductase A reduces atherosclerosis in apolipoprotein E-deficient mice.Bolstering cholesteryl ester hydrolysis in liver: A hepatocyte-targeting gene delivery strategy for potential alleviation of atherosclerosis.Intracellular cholesterol transport proteins enhance hydrolysis of HDL-CEs and facilitate elimination of cholesterol into bile Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr -/- mice.Sortilin 1 Modulates Hepatic Cholesterol Lipotoxicity in Mice via Functional Interaction with Liver Carboxylesterase 1.

P2860

Q34664855-9F17134C-07BB-4856-9C93-45E7EA54D4A3 Q35304688-141E213B-3EBD-45E2-AAED-678345A89D48 Q36093184-764B5645-2217-4B63-8283-9530A6E9B758 Q38871582-9D21AF39-D001-41D4-9E69-9D3B92EC68BE Q40666156-4CB8E824-78CB-4C7B-812F-9B4F578F76F7 Q47132750-CA4517C4-9178-4BF1-9181-81B056F27E52 Q49809354-05636566-4EA8-4D5F-8958-F709BFDFE4C6

P2860

Liver-specific transgenic expression of cholesteryl ester hydrolase reduces atherosclerosis in Ldlr-/- mice.

http://www.wikidata.org/entity/Q37665470

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Liver-specific transgenic expr ...... herosclerosis in Ldlr-/- mice.

@en

Liver-specific transgenic expr ...... herosclerosis in Ldlr-/- mice.

@nl

type

label

Liver-specific transgenic expr ...... herosclerosis in Ldlr-/- mice.

@en

Liver-specific transgenic expr ...... herosclerosis in Ldlr-/- mice.

@nl

prefLabel

Liver-specific transgenic expr ...... herosclerosis in Ldlr-/- mice.

@en

Liver-specific transgenic expr ...... herosclerosis in Ldlr-/- mice.

@nl

P1433

Q37665470-DAF2A1EC-366A-4D9D-B693-999544EAC9F3

P1476

Q37665470-D76F6BEA-A6E6-4BCE-AFE1-82BF07073D36

P2093

Q37665470-1B53B64B-A22C-450F-8DC0-49264832A233

Q37665470-3C626975-C9D4-4E28-83D7-F0CDB3325021

Q37665470-7F1036A4-D041-4BB9-9229-173686C25BA2

Q37665470-9EFF1E93-A365-4B96-9386-7BEAA1A491E8

Q37665470-F1867009-72AF-4F25-9621-31E8210EE8FC

Q37665470-F6DF1EEE-2B9A-4F5C-B390-33A973500F05

P2860

Q37665470-0307D8F8-55E2-4B7A-991C-1230EEE9EDED

Q37665470-0400B812-CEDE-4453-AB38-B8358591DFAD

Q37665470-063A2505-547C-4B78-8334-A70E265C5857

Q37665470-0C74257B-FD95-4467-B729-E91AEAD034D9

Q37665470-15227134-2D91-4977-9901-A402311DB3C8

Q37665470-157BFE07-1C3D-4D81-BC28-6088831AF8D9

Q37665470-165A35E1-B068-4569-9C5E-05B2E08D368E

Q37665470-17754267-DF61-4A04-8C3B-AB3236DF6355

Q37665470-1F1B2674-A099-4C25-8264-B4B5A9AF030D

Q37665470-208EE3EE-2627-4E83-8605-5244CC8F09C7

P304

Q37665470-78063662-7983-40BD-9313-7F463D8A478F

P31

Q37665470-829111B5-FE54-438F-AAE4-963548F9D0DD

P356

Q37665470-FC1C606D-A6B6-49C4-B0AE-A3AE3FF0E113

P433

Q37665470-9933EE32-3DB9-4848-8300-1192E4BF354E

P478

Q37665470-36B988D3-83D5-4844-B373-0A7732C6E648

P577

Q37665470-3BCBC726-2007-4E86-82DF-CC838BDAE3C7

P698

Q37665470-DFBF4089-5AE6-406E-AE5B-F284092DBE76

P921

Q37665470-E3DB38AE-ED52-430A-B716-8430823B5E9F

P932

Q37665470-C39DA9CB-8AA1-456D-BA8F-82858F83FAC8

P356

P1433

Journal of Lipid Research

P1476

Liver-specific transgenic expr ...... herosclerosis in Ldlr-/- mice.

@en

P2093

Genta Kakiyama

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Jinghua Bie

http://www.w3.org/2001/XMLSchema#string

Quan Yuan

http://www.w3.org/2001/XMLSchema#string

Shobha Ghosh

http://www.w3.org/2001/XMLSchema#string

Siddhartha S Ghosh

http://www.w3.org/2001/XMLSchema#string

P2860

Role of LXRs in control of lipogenesis

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure

Overexpression of cholesterol transporter StAR increases in vivo rates of bile acid synthesis in the rat and mouse

A receptor-mediated pathway for cholesterol homeostasis

Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr-/- mice

Atherosclerosis susceptibility Loci identified in an extremely atherosclerosis-resistant mouse strain.

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.

The association of bile acid excretion and atherosclerotic coronary artery disease.

Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice

P304

729-738

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M046524

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24563511

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3966706

http://www.w3.org/2001/XMLSchema#string